Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GAO report on FDA device program finds review delays based on date-of-submission cohort.

This article was originally published in The Gray Sheet

Executive Summary

GAO REPORT ON FDA MEDICAL DEVICE REVIEW PROGRAM illustrates the delays that drove reform efforts but does not address more recent improvements in premarket submission review times and backlog reductions. Using a cohort of applications based on the date of submission, the General Accounting Office report released Nov. 7 revisits dramatic increases in application review times in 1992 and 1993 and initial improvements in 1994.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT005020

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel